By Liv Osby HEALTH WRITER losby@greenvillenews.com
More widespread adoption of information technology can help the
country reduce some of the waste that adds to the nation's
escalating health-care costs, U.S. Senate Majority Leader Bill Frist
told doctors and other staff at Greenville Hospital System Thursday.
The Tennessee Republican was in town to campaign for South
Carolina politicians and stopped by GHS for a tour. While there, he
took a few questions. One was about the role of information
technology in health care.
Frist said the price of health care makes it unaffordable to
many, and yet waste, abuse and medical errors add to those costs.
The best way for government to help, he said, is to cultivate an
"interoperability platform" that allows for easier exchange of
information. That will help reduce those problems, and in turn
reduce costs, he said.
For instance, he said, there are many points along the way from
the writing of a prescription to filling it where a costly error can
occur. Technology could reduce the number of steps, and thereby the
chance for error.
Advertisement
|
 |
When asked about the increasing number of Americans traveling to
other countries for health-care services at a fraction of the U.S.
cost, Frist, a doctor, said he supports free trade and doesn't see
that as much of a problem -- at least not until insurers start
sending their subscribers overseas for care.
However, he said that in an age of global competition, the United
States needs to foster math and science education so that the
country remains competitive. One way to do that, he said, is
increase grants to students studying those and other high-tech
areas.
Frist also was asked about the value of stem-cell research. He
said it's an issue that is caught between advancing science and
moral issues and as a result needs to be re-examined every few
years. And though he said he favors embryonic stem cell research, he
also said he is pro-life.
He said this week's controversial announcement by a Massachusetts
company could be the answer to the dilemma that has pitted those who
favor stem cell research for a host of diseases against those who
oppose the practice as destroying human life. That company, Advanced
Cell Technology, claims it has been able to remove just one cell
from an embryo for research without destroying the embryo, although
that claim has been criticized |